Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACAD |
---|---|---|
09:32 ET | 6526 | 16.34 |
09:34 ET | 1875 | 16.39 |
09:36 ET | 1131 | 16.4 |
09:38 ET | 948 | 16.45 |
09:39 ET | 300 | 16.39 |
09:41 ET | 1035 | 16.34 |
09:43 ET | 600 | 16.2778 |
09:45 ET | 400 | 16.33 |
09:48 ET | 200 | 16.36 |
09:50 ET | 3136 | 16.29 |
09:52 ET | 5581 | 16.27 |
09:54 ET | 6114 | 16.28 |
09:56 ET | 1632 | 16.29 |
09:57 ET | 500 | 16.305 |
09:59 ET | 1304 | 16.265 |
10:01 ET | 959 | 16.33 |
10:03 ET | 100 | 16.35 |
10:06 ET | 4660 | 16.345 |
10:08 ET | 944 | 16.36 |
10:10 ET | 4924 | 16.36 |
10:12 ET | 557 | 16.37 |
10:14 ET | 600 | 16.4 |
10:15 ET | 800 | 16.41 |
10:17 ET | 1460 | 16.365 |
10:19 ET | 2002 | 16.41 |
10:21 ET | 774 | 16.41 |
10:24 ET | 400 | 16.405 |
10:26 ET | 650 | 16.42 |
10:28 ET | 6142 | 16.41 |
10:30 ET | 3890 | 16.395 |
10:32 ET | 977 | 16.41 |
10:33 ET | 862 | 16.424 |
10:35 ET | 2030 | 16.46 |
10:37 ET | 2942 | 16.44 |
10:39 ET | 1555 | 16.435 |
10:42 ET | 4315 | 16.435 |
10:44 ET | 6213 | 16.48 |
10:46 ET | 2485 | 16.51 |
10:48 ET | 8097 | 16.525 |
10:50 ET | 1709 | 16.53 |
10:51 ET | 18832 | 16.43 |
10:53 ET | 1600 | 16.43 |
10:55 ET | 2042 | 16.46 |
10:57 ET | 850 | 16.45 |
11:00 ET | 600 | 16.44 |
11:02 ET | 1120 | 16.4 |
11:04 ET | 1011 | 16.41 |
11:06 ET | 5315 | 16.4023 |
11:08 ET | 1344 | 16.41 |
11:09 ET | 950 | 16.38 |
11:11 ET | 450 | 16.39 |
11:13 ET | 3756 | 16.4 |
11:15 ET | 803 | 16.4 |
11:18 ET | 1916 | 16.3988 |
11:20 ET | 2819 | 16.4 |
11:22 ET | 2128 | 16.39 |
11:24 ET | 947 | 16.42 |
11:26 ET | 700 | 16.42 |
11:27 ET | 2389 | 16.47 |
11:29 ET | 4494 | 16.44 |
11:31 ET | 6632 | 16.45 |
11:33 ET | 3005 | 16.43 |
11:36 ET | 1855 | 16.434094 |
11:38 ET | 1600 | 16.43 |
11:40 ET | 900 | 16.45 |
11:44 ET | 2199 | 16.48 |
11:45 ET | 1250 | 16.48 |
11:47 ET | 700 | 16.496 |
11:49 ET | 2352 | 16.475 |
11:51 ET | 800 | 16.485 |
11:54 ET | 975 | 16.51 |
11:56 ET | 336 | 16.515 |
11:58 ET | 485 | 16.515 |
12:00 ET | 1846 | 16.515 |
12:02 ET | 1034 | 16.51 |
12:03 ET | 4050 | 16.46 |
12:05 ET | 3285 | 16.42 |
12:07 ET | 2020 | 16.45 |
12:09 ET | 983 | 16.465 |
12:12 ET | 432 | 16.46 |
12:14 ET | 3029 | 16.46 |
12:16 ET | 961 | 16.45 |
12:18 ET | 839 | 16.415 |
12:20 ET | 876 | 16.425 |
12:21 ET | 2559 | 16.4 |
12:23 ET | 1101 | 16.4099 |
12:25 ET | 800 | 16.41 |
12:27 ET | 400 | 16.41 |
12:30 ET | 4064 | 16.4 |
12:32 ET | 2901 | 16.395 |
12:34 ET | 6152 | 16.39 |
12:36 ET | 1753 | 16.41 |
12:38 ET | 750 | 16.41 |
12:39 ET | 300 | 16.41 |
12:41 ET | 1150 | 16.41 |
12:43 ET | 2776 | 16.405 |
12:45 ET | 4570 | 16.35 |
12:48 ET | 1645 | 16.355 |
12:50 ET | 2957 | 16.375 |
12:52 ET | 2252 | 16.375 |
12:54 ET | 2158 | 16.355 |
12:56 ET | 300 | 16.36 |
12:57 ET | 1087 | 16.37 |
12:59 ET | 694 | 16.36 |
01:01 ET | 797 | 16.36 |
01:03 ET | 400 | 16.36 |
01:06 ET | 1080 | 16.36 |
01:08 ET | 300 | 16.36 |
01:10 ET | 1166 | 16.36 |
01:12 ET | 16676 | 16.34 |
01:14 ET | 7724 | 16.285 |
01:15 ET | 400 | 16.24 |
01:17 ET | 500 | 16.2405 |
01:19 ET | 700 | 16.24 |
01:21 ET | 1660 | 16.28 |
01:24 ET | 100 | 16.27 |
01:26 ET | 300 | 16.26 |
01:28 ET | 900 | 16.28 |
01:30 ET | 1400 | 16.28 |
01:32 ET | 3218 | 16.32 |
01:33 ET | 958 | 16.33 |
01:35 ET | 200 | 16.34 |
01:37 ET | 596 | 16.34 |
01:39 ET | 1473 | 16.35 |
01:42 ET | 1071 | 16.33 |
01:44 ET | 700 | 16.32 |
01:46 ET | 3350 | 16.285 |
01:48 ET | 9270 | 16.25 |
01:50 ET | 950 | 16.24 |
01:51 ET | 840 | 16.26 |
01:53 ET | 300 | 16.25 |
01:55 ET | 400 | 16.25 |
01:57 ET | 600 | 16.25 |
02:00 ET | 1550 | 16.25 |
02:02 ET | 3899 | 16.22 |
02:04 ET | 1078 | 16.23 |
02:06 ET | 1772 | 16.255 |
02:08 ET | 2737 | 16.26 |
02:09 ET | 3324 | 16.25 |
02:11 ET | 714 | 16.27 |
02:13 ET | 1300 | 16.275 |
02:15 ET | 1333 | 16.3 |
02:18 ET | 846 | 16.34 |
02:20 ET | 570 | 16.345 |
02:22 ET | 6355 | 16.34 |
02:24 ET | 431 | 16.35 |
02:26 ET | 1145 | 16.34 |
02:27 ET | 972 | 16.35 |
02:29 ET | 1600 | 16.385 |
02:31 ET | 616 | 16.385 |
02:33 ET | 1403 | 16.38 |
02:36 ET | 306 | 16.38 |
02:38 ET | 1194 | 16.375 |
02:40 ET | 1263 | 16.38 |
02:42 ET | 200 | 16.38 |
02:44 ET | 1761 | 16.385 |
02:45 ET | 1798 | 16.4 |
02:47 ET | 1624 | 16.41 |
02:49 ET | 1500 | 16.395 |
02:51 ET | 2839 | 16.37 |
02:54 ET | 1284 | 16.35 |
02:56 ET | 1000 | 16.35 |
02:58 ET | 2642 | 16.345 |
03:00 ET | 2557 | 16.33 |
03:02 ET | 1449 | 16.33 |
03:03 ET | 1655 | 16.33 |
03:05 ET | 2144 | 16.32 |
03:07 ET | 4423 | 16.35 |
03:09 ET | 1399 | 16.36 |
03:12 ET | 2961 | 16.345 |
03:14 ET | 1500 | 16.355 |
03:16 ET | 1697 | 16.36 |
03:18 ET | 2427 | 16.365 |
03:20 ET | 3658 | 16.375 |
03:21 ET | 4073 | 16.36 |
03:23 ET | 4475 | 16.36 |
03:25 ET | 1507 | 16.36 |
03:27 ET | 2900 | 16.335 |
03:30 ET | 5425 | 16.375 |
03:32 ET | 3770 | 16.345 |
03:34 ET | 4399 | 16.36 |
03:36 ET | 2455 | 16.36 |
03:38 ET | 2854 | 16.365 |
03:39 ET | 3622 | 16.33 |
03:41 ET | 5075 | 16.35 |
03:43 ET | 4142 | 16.29 |
03:45 ET | 2425 | 16.28 |
03:48 ET | 2651 | 16.28 |
03:50 ET | 3692 | 16.275 |
03:52 ET | 9183 | 16.26 |
03:54 ET | 3166 | 16.25 |
03:56 ET | 7950 | 16.23 |
03:57 ET | 9534 | 16.2475 |
03:59 ET | 221590 | 16.29 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
ACADIA Pharmaceuticals Inc | 2.7B | 89.8x | --- |
Azenta Inc | 2.4B | -17.4x | --- |
Guardant Health Inc | 3.1B | -5.7x | --- |
PTC Therapeutics Inc | 2.8B | -5.8x | --- |
Novavax Inc | 2.1B | -4.6x | --- |
Catalyst Pharmaceuticals Inc | 2.5B | 38.4x | --- |
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.7B |
---|---|
Revenue (TTM) | $890.5M |
Shares Outstanding | 165.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.39 |
EPS | $0.18 |
Book Value | $2.62 |
P/E Ratio | 89.8x |
Price/Sales (TTM) | 3.1 |
Price/Cash Flow (TTM) | 65.2x |
Operating Margin | 2.56% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.